Amplifon stock: Bernstein keeps EUR 11.10 target for Amplifon stock

Published on 10/19/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue was EUR 1.19 billion in first half 2026. Amplifon stock costs EUR 12.32 on October 19, 2026, down 1.83 percent versus Borsa Italiana close.

Analyst target and reporting date

Bernstein analyst Susannah Ludwig maintained a Hold rating and an EUR 11.10 target on October 16, 2026.
Amplifon revenue reached EUR 1.19 billion in the first half of 2026, up 1.30 percent at constant exchange rates.
Amplifon stock costs EUR 12.32 at Lang & Schwarz on October 19, 2026 at 3:02 p.m. CEST, down 1.83 percent versus the Borsa Italiana close of October 16, 2026.
Amplifon is scheduled to publish its third-quarter and nine-month results on October 29, 2026.

Dokumentarische Schwarzweißaufnahme einer Hörgeräte-Anpassung beim Facharzt — Schwarzweiß-Reportagefoto dokumentiert eine authentische Hörtest-Szene, thematisch verbunden mit Amplifon S.p.A., ISIN IT0004056880, Gesundheitssektor, Illustration mit AI erstellt.

Bernstein analyst Susannah Ludwig maintained a Hold rating on Amplifon and set an EUR 11.10 price target in a report dated October 16, 2026, according to Markets Insider. The target is below the current euro quotation. Amplifon stock was trading at EUR 12.32 at Lang & Schwarz on October 19, 2026 at 3:02 p.m. CEST, down 1.83 percent versus the Borsa Italiana close of October 16, 2026 at EUR 12.55.

First-half revenue reached EUR 1.19 billion

Amplifon reported first-half 2026 revenue of EUR 1.19 billion, an increase of 1.30 percent at constant exchange rates, while organic growth reached 3.50 percent. Adjusted EBITDA rose 3.60 percent to EUR 298.00 million, and the adjusted EBITDA margin increased to 25.10 percent. These figures were reported in coverage by Capital.com, which dated the results to July 30, 2026.

Stock sits below its yearly high

The current EUR 12.32 quotation stands 22.22 percent below Amplifon's 52-week high of EUR 15.84 and 57.14 percent above its 52-week low of EUR 7.84. The market capitalization is EUR 2.7 billion, the trailing P/E ratio is 40.78, and the latest session volume was 349,209 shares against an average of 1,545,673 shares.

Valuation and October 29 reporting date

Investing.com listed an average 12-month target of EUR 13.63 from 16 analysts, with seven Buy ratings and nine Hold ratings, in data updated October 18, 2026. The average target is 10.63 percent above EUR 12.32. Amplifon is scheduled to publish its third-quarter and nine-month results on October 29, 2026, according to the company's Amplifon Corporate notice dated September 29, 2026.

Comparison with peers

On October 19, 2026, the following figures described the listed hearing-care group and two peers:

Amplifon (Borsa Italiana, EUR): minus 1.83 percent, P/E 40.78, market capitalization EUR 2.7 billion.
Demant (Nasdaq Copenhagen, DKK): minus 0.67 percent, P/E 46.23, market capitalization DKK 75.2 billion.
Sonova (SIX, CHF): minus 0.07 percent, P/E 38.45, market capitalization CHF 16.5 billion.

Price and trading outlook

Amplifon combines a 40.78 P/E ratio with first-half organic growth of 3.50 percent and an October 29 reporting date. The next results will provide a fresh test of revenue growth, adjusted margins and the financial implications of the GN Hearing transaction.

The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.